Clinical review: aggressive management and extracorporeal support for drug-induced cardiotoxicity.
Poisoning may induce failure in multiple organs, leading to death. Supportive treatments and supplementation of failing organs are usually efficient. In contrast, the usefulness of cardiopulmonary bypass in drug-induced shock remains a matter of debate. The majority of deaths results from poisoning with membrane stabilising agents and calcium channel blockers. There is a need for more aggressive treatment in patients not responding to conventional treatments. The development of new antidotes is limited. In contrast, experimental studies support the hypothesis that cardiopulmonary bypass is life-saving. A review of the literature shows that cardiopulmonary bypass of the poisoned heart is feasible. The largest experience has resulted from the use of peripheral cardiopulmonary bypass. However, a literature review does not allow any conclusions regarding the efficiency and indications for this invasive method. Indeed, the majority of reports are single cases, with only one series of seven patients. Appealing results suggest that further studies are needed. Determination of prognostic factors predictive of refractoriness to conventional treatment for cardiotoxic poisonings is mandatory. These prognostic factors are specific for a toxicant or a class of toxicants. Knowledge of them will result in clarification of the indications for cardiopulmonary bypass in poisonings.
Baud
Frédéric J
FJ
Medical and Toxicological Intensive Care Unit, Assistance Publique-Hôpitaux de Paris, University Paris 7, Hôpital Lariboisière, 75010 Paris, France. frederic.baud@lrb.aphp.fr
Megarbane
Bruno
B
Deye
Nicolas
N
Leprince
Pascal
P
D000818:Animals; D002315:Cardiopulmonary Bypass; D015199:Extracorporeal Membrane Oxygenation; D006801:Humans; D011041:Poisoning / Q000628:therapy*; D011379:Prognosis; D012770:Shock, Cardiogenic / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy*